Tijana Stanković

859 total citations
34 papers, 670 citations indexed

About

Tijana Stanković is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Tijana Stanković has authored 34 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Tijana Stanković's work include Drug Transport and Resistance Mechanisms (9 papers), Glioma Diagnosis and Treatment (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Tijana Stanković is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Glioma Diagnosis and Treatment (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Tijana Stanković collaborates with scholars based in Serbia, Spain and Portugal. Tijana Stanković's co-authors include Milica Pešić, Jelena Dinić, Jasna Banković, Ana Podolski-Renić, Nikola Tanić, Zorica Milošević, Sabera Ruždijić, Aleksandra Isaković, Sandor Kasas and Mónica Suárez Korsnes and has published in prestigious journals such as PLoS ONE, Experimental Cell Research and Phytochemistry.

In The Last Decade

Tijana Stanković

32 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tijana Stanković Serbia 18 386 183 115 92 80 34 670
ŞERBAN COMŞA Romania 7 379 1.0× 245 1.3× 130 1.1× 110 1.2× 36 0.5× 13 854
Zhongyuan Xu China 17 253 0.7× 98 0.5× 66 0.6× 128 1.4× 59 0.7× 59 686
Alok Ranjan United States 18 610 1.6× 242 1.3× 221 1.9× 62 0.7× 90 1.1× 38 1.1k
Rossella Marullo United States 9 541 1.4× 270 1.5× 160 1.4× 65 0.7× 33 0.4× 18 969
Indu Parmar Canada 8 648 1.7× 252 1.4× 76 0.7× 177 1.9× 64 0.8× 12 1.2k
Jasna Banković Serbia 19 599 1.6× 233 1.3× 185 1.6× 56 0.6× 36 0.5× 34 845
Xiaoying Lan China 15 461 1.2× 227 1.2× 77 0.7× 76 0.8× 35 0.4× 20 699
Iwona Wertel Poland 20 336 0.9× 323 1.8× 104 0.9× 35 0.4× 39 0.5× 75 1.1k
Mihail Buse Romania 8 511 1.3× 180 1.0× 176 1.5× 48 0.5× 25 0.3× 14 878
Peng Zou China 13 644 1.7× 208 1.1× 256 2.2× 69 0.8× 67 0.8× 25 1.1k

Countries citing papers authored by Tijana Stanković

Since Specialization
Citations

This map shows the geographic impact of Tijana Stanković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tijana Stanković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tijana Stanković more than expected).

Fields of papers citing papers by Tijana Stanković

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tijana Stanković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tijana Stanković. The network helps show where Tijana Stanković may publish in the future.

Co-authorship network of co-authors of Tijana Stanković

This figure shows the co-authorship network connecting the top 25 collaborators of Tijana Stanković. A scholar is included among the top collaborators of Tijana Stanković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tijana Stanković. Tijana Stanković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Stanković, Tijana, Jela Milić, Miloš Petković, et al.. (2025). Intravenous Nanoemulsions Loaded with Phospholipid Complex of a Novel Pyrazoloquinolinone Ligand for Enhanced Brain Delivery. Pharmaceutics. 17(2). 232–232.
3.
Stanković, Tijana, et al.. (2021). In vitro biomimetic models for glioblastoma-a promising tool for drug response studies. Drug Resistance Updates. 55. 100753–100753. 42 indexed citations
4.
Podolski-Renić, Ana, Jelena Dinić, Tijana Stanković, et al.. (2019). Modulation of Antioxidant Potential with Coenzyme Q10 Suppressed Invasion of Temozolomide-Resistant Rat Glioma In Vitro and In Vivo. Oxidative Medicine and Cellular Longevity. 2019. 1–14. 19 indexed citations
5.
Fallacara, Anna Lucia, Claudio Zamperini, Ana Podolski-Renić, et al.. (2019). A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor. Cancers. 11(6). 848–848. 39 indexed citations
6.
Luca, Andrei, Sandor Kasas, Tijana Stanković, et al.. (2019). Advanced technological tools to study multidrug resistance in cancer. Drug Resistance Updates. 48. 100658–100658. 56 indexed citations
7.
Banković, Jasna, et al.. (2018). Association of overexpressed MYC gene with altered PHACTR3 and E2F4 genes contributes to non-small cell lung carcinoma pathogenesis. Journal of Medical Biochemistry. 38(2). 188–195. 14 indexed citations
8.
García, Catarina, Catarina Oliveira Silva, Marisa Nicolai, et al.. (2018). Anticancer Properties of the Abietane Diterpene 6,7-dehydroroyleanone Obtained by Optimized Extraction. Future Medicinal Chemistry. 10(10). 1177–1189. 21 indexed citations
9.
Banković, Jasna, Evangelia Sereti, Sofija Jovanović Stojanov, et al.. (2017). Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors. Investigational New Drugs. 35(6). 718–732. 10 indexed citations
10.
Podolski-Renić, Ana, Zorica Milošević, Jelena Dinić, et al.. (2016). Mutual regulation and targeting of multidrug resistance and cancer stem phenotype. MedChemComm. 7(12). 2265–2281. 2 indexed citations
11.
12.
Stanković, Tijana, Ana Martins, Aleksandra Isaković, et al.. (2015). Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives. Cancer Chemotherapy and Pharmacology. 76(3). 555–565. 17 indexed citations
13.
Dinić, Jelena, Ana Podolski-Renić, Tijana Stanković, Jasna Banković, & Milica Pešić. (2015). New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer. Current Pharmaceutical Design. 21(38). 5589–5604. 35 indexed citations
14.
Podolski-Renić, Ana, Jelena Dinić, Tijana Stanković, et al.. (2015). Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin. Experimental Cell Research. 335(2). 248–257. 17 indexed citations
15.
Stanković, Tijana, Jasna Banković, Jelena Dinić, et al.. (2014). Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples. Biomedicine & Pharmacotherapy. 68(5). 521–526. 10 indexed citations
16.
Milošević, Zorica, Milica Pešić, Tijana Stanković, et al.. (2014). Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma. Translational research. 164(5). 411–423. 46 indexed citations
17.
Banković, Jasna, et al.. (2013). Identification of Novel Genetic Alterations in Samples of Malignant Glioma Patients. PLoS ONE. 8(12). e82108–e82108. 25 indexed citations
18.
Isaković, Aleksandra, Ana Podolski-Renić, Tijana Stanković, et al.. (2013). Purine Nucleoside Analog - Sulfinosine Modulates Diverse Mechanisms of Cancer Progression in Multi-Drug Resistant Cancer Cell Lines. PLoS ONE. 8(1). e54044–e54044. 20 indexed citations
19.
Podolski-Renić, Ana, Milka Jadranin, Tijana Stanković, et al.. (2013). Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing. Cancer Chemotherapy and Pharmacology. 72(3). 683–697. 31 indexed citations
20.
Banković, Jasna, Nebojša T. Milošević, Tijana Stanković, et al.. (2012). Genomic instability and p53 alterations in patients with malignant glioma. Experimental and Molecular Pathology. 93(2). 200–206. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by ŞERBAN COMŞA Breakdown of academic impact, for papers by Zhongyuan Xu Breakdown of academic impact, for papers by Alok Ranjan Breakdown of academic impact, for papers by Rossella Marullo Breakdown of academic impact, for papers by Indu Parmar Breakdown of academic impact, for papers by Jasna Banković Breakdown of academic impact, for papers by Xiaoying Lan Breakdown of academic impact, for papers by Iwona Wertel Breakdown of academic impact, for papers by Mihail Buse Breakdown of academic impact, for papers by Peng Zou
Rankless by CCL
2026